Compositions and methods for inhibiting EB-1-mediated microtubule stability
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 28, 2010
Issued Date -
N/A
app pub date -
Jul 14, 2006
filing date -
Jul 15, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This invention provides a recombinant nucleic acid which, when introduced in vivo into a mammalian cell endogenously expressing EB1, inhibits the expression of EB1 therein, thereby reducing the amount of stable microtubules in the cell.This invention further provides related compositions, nucleic acids, cells and methods.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully